Abraham Boskovitz
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
-
- MicroRNA in disease regulation
Papers in
-
- Glycosylation and Glycoproteins Research 2
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Degradation and Inhibitors 1
-
- Radiopharmaceutical Chemistry and Applications 3
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Michael R. Zalutsky (6 shared papers)Al Charest (1 shared paper)Rolf Pfannl (2 shared papers)John W. Chen (1 shared paper)David E. Housman (2 shared papers)Steve Woolfenden (2 shared papers)Ralph Weissleder (1 shared paper)Roderick T. Bronson (1 shared paper)
- Journals
- Nuclear Medicine and Biology (3 papers)Proceedings of the National Academy of Sciences (1 paper)Expert Opinion on Biological Therapy (1 paper)Peptides (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesEgyptSouth Korea
In The Last Decade
Abraham Boskovitz
8 papers receiving 368 citations
Peers
Comparison fields: 5 of 44
- Genetics 119
- Cancer Research 81
- Radiology, Nuclear Medicine and Imaging 88
- Oncology 72
- Developmental Neuroscience 11
Countries citing papers authored by Abraham Boskovitz
This map shows the geographic impact of Abraham Boskovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Boskovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Boskovitz more than expected).
Fields of papers citing papers by Abraham Boskovitz
This network shows the impact of papers produced by Abraham Boskovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Boskovitz. The network helps show where Abraham Boskovitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Abraham Boskovitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 186 | |
| 2 | 2015 | 46 | |
| 3 | 2009 | 40 | |
| 4 | 2004 | 38 | |
| 5 | 2011 | 29 | |
| 6 | 2004 | 28 | |
| 7 | 2004 | 12 | |
| 8 | 2011 | 1 | |
| 9 | 2007 | 0 |
About Abraham Boskovitz
Abraham Boskovitz is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Genetics, Epidemiology and Pathology and Forensic Medicine, having authored 9 papers that have together received 380 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (3 papers), Glycosylation and Glycoproteins Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Glioma Diagnosis and Treatment (2 papers), Cancer Mechanisms and Therapy (1 paper), Lung Cancer Research Studies (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Genetics (119 citations), Cancer Research (81 citations), Radiology, Nuclear Medicine and Imaging (88 citations), Oncology (72 citations) and Developmental Neuroscience (11 citations). Abraham Boskovitz has collaborated with scholars based in United States, Egypt and South Korea. Frequent co-authors include Michael R. Zalutsky, Al Charest, Rolf Pfannl, John W. Chen, David E. Housman, Steve Woolfenden, Ralph Weissleder, Roderick T. Bronson, Jaime Acquaviva and Haihao Zhu. Their work appears in journals such as Nuclear Medicine and Biology, Proceedings of the National Academy of Sciences, Expert Opinion on Biological Therapy, Peptides and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.